Credit: Pixelvario/

The recent passage of the Inflation Reduction Act of 2022 (IRA) has significant health insurance implications for Americans, with $98 billion of its $485 billion in spending going to health care programs. This spending is mostly in the area of expanding government subsidies for those on Affordable Care Act (ACA) individual plans — but the plan also saves money by redesigning Medicare pharmacy spending to include negotiating prices for some drugs. An analysis by the Kaiser Family Foundation estimated that the drug pricing provisions would save the government close to $100 billion over ten years.

Read more: How does the Inflation Reduction Act affect self-funded plans?

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.